Search results
Moderna Executive Says Expects To File For Approval Of RSV Vaccine For Adults Aged 18-59 In 2024 -...
Benzinga· 6 days agoNever miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 3 days agoModerna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults age 18 and older compared with its ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Worried you missed the Nvidia bandwagon? Here are some alternative stocks.
MarketWatch via Yahoo Finance· 1 day agoENPH 33.2% 47.0% 32.9 28.0 -28% EQT...Corp. EQT 26.4% 84.8% 16.0 11.3 16% Nvidia Corp. NVDA 25.8%...
Stocks to Watch Monday: Nvidia, Apple, AMD, Southwest Airlines
The Wall Street Journal· 6 days ago**Nvidia (NVDA)**: The AI chip designer split its stock 10-for-1 after trading closed on Friday....
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 6 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
US stocks slip lower; caution ahead of Fed meeting, key CPI release By Investing.com
Investing.com· 7 days agoInvesting.com-- U.S. stocks edged lower Monday, handing back some of the prior week's strong gains...
Apple Intelligence, Musk Reacts, Equal-Weighted S&P Signal? Trading Moderna
TheStreet.com· 5 days agoThe goal on Monday was probably to convince investors that Apple is not falling way behind in the...
Combo COVID/flu vaccine elicits higher immune response in trial
UPI· 6 days agoThe new vaccine contains components of mRNA-1010, Moderna's vaccine candidate for seasonal...